Pharmacokinetic parameters in CNS Gd-DTPA enhanced MR imaging.
about
Intraoperative perfusion magnetic resonance imaging: Cutting-edge improvement in neurosurgical proceduresQuantitative imaging of tumour blood flow by contrast-enhanced magnetic resonance imagingQuantitative serial MRI of the treated fibroid uterusSelf-assembled gemcitabine-gadolinium nanoparticles for magnetic resonance imaging and cancer therapy.Radiation treatment monitoring using multimodal functional imaging: PET/CT ((18)F-Fluoromisonidazole & (18)F-Fluorocholine) and DCE-US.Perfusion MRI: the five most frequently asked technical questionsPractical dynamic contrast enhanced MRI in small animal models of cancer: data acquisition, data analysis, and interpretationParameter optimization for quantitative signal-concentration mapping using spoiled gradient echo MRI.DCE@urLAB: a dynamic contrast-enhanced MRI pharmacokinetic analysis tool for preclinical data.Dynamic contrast-enhanced magnetic resonance imaging: fundamentals and application to the evaluation of the peripheral perfusionTumor vascular permeability to a nanoprobe correlates to tumor-specific expression levels of angiogenic markers.Dynamic Contrast Enhanced Magnetic Resonance Imaging in Oncology: Theory, Data Acquisition, Analysis, and ExamplesHigh-resolution magnetic resonance colonography and dynamic contrast-enhanced magnetic resonance imaging in a murine model of colitis.Platelet-derived growth factor-B normalizes micromorphology and vessel function in vascular endothelial growth factor-A-induced squamous cell carcinomasDynamic-contrast-enhanced-MRI with extravasating contrast reagent: rat cerebral glioma blood volume determination.Pharmacokinetic analysis of tissue microcirculation using nested models: multimodel inference and parameter identifiability.Influence of B1-Inhomogeneity on Pharmacokinetic Modeling of Dynamic Contrast-Enhanced MRI: A Simulation StudyKnee subchondral bone perfusion and its relationship to marrow fat and trabeculation on multi-parametric MRI and micro-CT in experimental CKD.Muscle-based pharmacokinetic modeling of marrow perfusion for osteoporotic bone in females.Brain capillary transit time heterogeneity in healthy volunteers measured by dynamic contrast-enhanced T1 -weighted perfusion MRI.Principal component analysis of breast DCE-MRI adjusted with a model-based methodChanges in magnetic resonance bone marrow angiogenesis on day 7 after induction chemotherapy can predict outcome of acute myeloid leukemia.Diagnosis of suspicious breast lesions using an empirical mathematical model for dynamic contrast-enhanced MRI.Modeling the effect of intra-voxel diffusion of contrast agent on the quantitative analysis of dynamic contrast enhanced magnetic resonance imaging.Magnetic resonance imaging: a potential tool in assessing the addition of hyperthermia to neoadjuvant therapy in patients with locally advanced breast cancerThe use of dynamic tracer concentration in veins for quantitative DCE-MRI kinetic analysis in head and neck.The effects of applying breast compression in dynamic contrast material-enhanced MR imagingImpact of nonrigid motion correction technique on pixel-wise pharmacokinetic analysis of free-breathing pulmonary dynamic contrast-enhanced MR imagingPrediction of chemotherapeutic response in bladder cancer using K-means clustering of dynamic contrast-enhanced (DCE)-MRI pharmacokinetic parameters.Trimodal glioblastoma treatment consisting of concurrent radiotherapy, temozolomide, and the novel TGF-β receptor I kinase inhibitor LY2109761.Improving bladder cancer imaging using 3-T functional dynamic contrast-enhanced magnetic resonance imaging.Small changes in bone structure of female α7 nicotinic acetylcholine receptor knockout mice.Evaluation of antiangiogenic effects of a new synthetic candidate drug KR-31831 on xenografted ovarian carcinoma using dynamic contrast enhanced MRI.Liposomal doxorubicin improves radiotherapy response in hypoxic prostate cancer xenograftsAssessment of blood-brain barrier disruption using dynamic contrast-enhanced MRI. A systematic review.Effect of arterial deprivation on growing femoral epiphysis: quantitative magnetic resonance imaging using a piglet model.Synergistic Effect of Anti-Angiogenic and Radiation Therapy: Quantitative Evaluation with Dynamic Contrast Enhanced MR Imaging.Validation of dynamic contrast-enhanced magnetic resonance imaging-derived vascular permeability measurements using quantitative autoradiography in the RG2 rat brain tumor model.Integration of DCE-MRI and DW-MRI Quantitative Parameters for Breast Lesion ClassificationIV Administered Gadodiamide Enters the Lumen of the Prostatic Glands: X-Ray Fluorescence Microscopy Examination of a Mouse Model.
P2860
Q26827229-9E9464AF-D874-4C64-8182-9311F6C4D383Q28366234-E47CB0BB-5E58-4C3F-AC67-6AC22489BF4FQ28540610-16EF0F88-C29B-42C7-9B68-AFED92E0F4F3Q30361067-2D50DEAE-6060-4CF2-922C-98528942501AQ30395717-D23B6B55-5640-4A25-AD79-7913839EF1CAQ30421969-310C95DC-23BD-41C1-8BE8-B24A20D56E8CQ30575110-D21DE468-6610-4A21-AD20-2B45A1144F17Q30580232-120FD894-C0AC-4B9E-AFCC-69700375FE19Q30687678-AB61BD7F-F402-4429-9B41-9D8E624B3C68Q30822146-736C2F31-DB52-4336-B7CA-8636FC2E33E9Q33464944-4B08C7C5-1693-4070-AEF6-6245544541FCQ33510695-776FBF92-07FF-4B40-9021-DB83D4CF2C94Q33550441-B5E47921-9A62-44EA-B308-716A92772473Q33597254-1554E733-9F2F-4F41-87A6-D49BE43F6D87Q33646272-95E1DC40-529E-4359-A6BA-25392DE6ACCAQ33703176-D72E1990-3FB5-4F81-AE4B-D64410B23B3BQ33736299-CC482897-38CD-4948-99E2-FBC01431609FQ33780045-5675B39B-6100-496A-A25D-A8075A74FD08Q33805017-1A802B17-D1C0-462C-A1AC-20F0B8DE783DQ33833994-DB3F2742-5658-4D4A-8F3C-8CFFE4357931Q33856135-9D2166D7-AB46-4F8E-B781-4409C549C107Q34032273-1A75DEF7-2DEC-4FAE-A822-CEBBEED6F432Q34078035-199CF83F-DFCD-4F66-A616-5726C825A2D6Q34282239-16165D8E-67B2-4630-A7B9-D9534F27C40FQ34390068-89304320-60EB-49E8-9A3A-5DCBDB5A9272Q34635573-9A4A5DAE-6414-41E0-B9E1-0AD5C7D0DAC2Q34681250-3597E1BE-AEE8-407E-8AD0-AFED0D180DB3Q34754745-262F9B15-4FAB-480B-9D02-D03580C90501Q34982947-7175BE22-3637-458F-8E0B-07AD2AF0DE46Q35042985-65C41C68-CD17-4E67-992E-3B77E0EE616DQ35078389-17794386-6250-405D-AF59-B467AE374695Q35083443-A43D67B9-8691-45E7-A141-6DBABB3335E8Q35201734-575C896A-9B3C-418C-A538-9A5BC784C72AQ35352837-FF44AF7A-2539-4ABB-87BB-DD81E0505734Q35402503-03BE0300-560D-4D7E-A2A4-3C0772E7B895Q35620000-B61BAB48-2386-46DC-98D6-DAE76A6CAA25Q35919459-AC4AE182-0EC5-4A30-A403-53552D1BA271Q35925126-E30FBDF7-299D-4980-AE8C-F9FFDB2C3039Q35960422-04FFA311-22CC-4E28-81F2-C3375E7CF804Q36135624-1EE4C5FD-8065-4FCC-A632-D4E0B1104ADC
P2860
Pharmacokinetic parameters in CNS Gd-DTPA enhanced MR imaging.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
1991年论文
@zh
1991年论文
@zh-cn
name
Pharmacokinetic parameters in CNS Gd-DTPA enhanced MR imaging.
@en
Pharmacokinetic parameters in CNS Gd-DTPA enhanced MR imaging.
@nl
type
label
Pharmacokinetic parameters in CNS Gd-DTPA enhanced MR imaging.
@en
Pharmacokinetic parameters in CNS Gd-DTPA enhanced MR imaging.
@nl
prefLabel
Pharmacokinetic parameters in CNS Gd-DTPA enhanced MR imaging.
@en
Pharmacokinetic parameters in CNS Gd-DTPA enhanced MR imaging.
@nl
P2093
P1476
Pharmacokinetic parameters in CNS Gd-DTPA enhanced MR imaging
@en
P2093
P304
P356
10.1097/00004728-199107000-00018
P577
1991-07-01T00:00:00Z